• 1. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 2. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Introduction to 3-(4-Oxo-3,4-Dihydroquinazolin-3-Yl)Propanenitrile (CAS No. 7455-91-6)

The compound 3-(4-Oxo-3,4-dihydroquinazolin-3-yl)propanenitrile, identified by the CAS registry number CAS No. 7455-91-6, is a significant molecule in the field of organic chemistry and pharmacology. This compound belongs to the class of quinazoline derivatives, which have garnered considerable attention due to their diverse biological activities and potential applications in drug discovery.

The structure of 3-(4-Oxo-3,4-dihydroquinazolin-3-yl)propanenitrile comprises a quinazoline ring system with a nitrile group attached via a propyl chain. The quinazoline moiety is a heterocyclic aromatic compound with two nitrogen atoms at positions 1 and 3 of the benzene ring. The presence of the nitrile group introduces additional functional diversity, making this compound a versatile building block for further chemical modifications.

Recent studies have highlighted the potential of CAS No. 7455-91-6 as a lead compound in the development of anticancer agents. Researchers have demonstrated that this compound exhibits selective cytotoxicity against various cancer cell lines, suggesting its role in inhibiting key enzymes or signaling pathways involved in tumor progression.

In addition to its pharmacological applications, 3-(4-Oxo-3,4-dihydroquinazolin-3-Yl)Propanenitrile has been explored for its role in materials science. Its unique electronic properties make it a candidate for use in organic electronics, such as semiconductors and light-emitting diodes (LEDs). Recent advancements in synthetic methodologies have enabled the scalable production of this compound, facilitating its integration into next-generation electronic devices.

The synthesis of CAS No. 7455-91-6 typically involves multi-step reactions, including nucleophilic substitutions and cyclizations. These processes require precise control over reaction conditions to ensure high yields and purity. The development of efficient synthetic routes has been an active area of research, driven by the increasing demand for this compound in both academic and industrial settings.

In terms of biological activity, 3-(4-Oxo-3,4-dihydroquinazolin-3-Yl)Propanenitrile has shown promise as an inhibitor of protein kinases, which are critical targets in the treatment of various diseases, including cancer and inflammatory disorders. Preclinical studies have revealed that this compound can modulate kinase activity without causing significant toxicity to normal cells, making it a promising candidate for further therapeutic development.

The application of computational chemistry tools has significantly enhanced our understanding of the molecular interactions involving CAS No. 7455-91-6. Molecular docking studies have provided insights into how this compound binds to target proteins, paving the way for rational drug design strategies. Furthermore, computational modeling has facilitated the prediction of pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), which are crucial for determining its suitability as a drug candidate.

In conclusion, 3-(4-Oxo-3,4-dihydroquinazolin-3-Yl)Propanenitrile, with its unique chemical structure and diverse functional groups, represents a valuable molecule with broad applications across multiple disciplines. Ongoing research continues to uncover new avenues for its utilization, underscoring its importance in both academic and industrial contexts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)